Altrazeal Life Sciences Inc.
Healthcare · Pharmaceutical Preparations · NV · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | |
|---|---|---|---|---|---|---|
| Revenue | $717,157 | $442,565 | $935,739 | $863,857 | $370,568 | $60,005 |
| Operating income | −$1.7M | −$4.3M | −$2.4M | −$2.9M | −$2.6M | −$819,712 |
| Net income | −$1.9M | −$4.5M | −$2.7M | −$1.9M | −$3.1M | −$843,409 |
| Total assets | $8.5M | $4.3M | $7.4M | $5.5M | $5.9M | $7.3M |
| Total liabilities | $2.4M | $2.8M | $3.2M | $2.7M | $4.2M | $5.5M |
| Equity | $6.1M | $1.6M | $4.2M | $2.8M | $1.7M | $1.9M |
| EPS (diluted) | — | — | — | — | — | — |
| Shares out. | 201.3M | 63.0M | 36.8M | 24.5M | 18.9M | 10.1M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2017- Operating margin
- −242.3%
- Net margin
- −270.0%
- Return on equity
- −31.7%
- Return on assets
- −22.7%
- Return on capital (ROCE)
- −24.7%
- Liabilities / assets
- 28.5%
- Debt / equity
- 0.40×
- Book value / share
- $0.03
- Revenue growth (YoY)
- 62.0%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2017- Altman Z″ (distress)
- -20.24distress
- Accruals / assets
- 3.1%clean
- Beneish M-Score
- -0.10elevated
- Piotroski F-Score
- 4/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 2 severe● 4 warning● 3 good- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- Negative operating cash flow
- Beneish M-Score elevated — earnings-manipulation screen flag
- Revenue is growing year-over-year
- Conservative leverage (liabilities < 50% of assets)
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Kmissed a reporting deadline ↗Mar 31, 2017
- NT 10-Kmissed a reporting deadline ↗Apr 1, 2015
- NT 10-Qmissed a reporting deadline ↗Nov 14, 2006
- NT 10-Qmissed a reporting deadline ↗Aug 14, 2006
- NT 10-Qmissed a reporting deadline ↗May 15, 2006
- NT 10-Kmissed a reporting deadline ↗Mar 30, 2006
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Material events
SEC Form 8-K · most recent- Delisting / listing-standard notice · Other material eventFeb 5, 2019
- Director / officer changeDec 7, 2018
- Shareholder voteJun 12, 2018
- Changed auditorApr 26, 2018
- Entered a material agreement · Terminated a material agreementDec 20, 2017
- Amended charter or bylaws · Shareholder voteJul 27, 2017
- Entered a material agreement · New financial obligation · Unregistered equity sale · Change in control · Director / officer change · Amended charter or bylaws · Regulation FD disclosureApr 3, 2017
- Entered a material agreement · New financial obligation · Unregistered equity sale · Director / officer change · Regulation FD disclosureMar 1, 2017
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.